Order Article Reprints

Rodríguez-Lobato LG, Tovar N, de Daniel A, Fernández de Larrea C, Cibeira MT, Jiménez-Segura R, Moreno DF, Oliver-Caldés A, Bladé J, Rosiñol L. Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution. Cancers. 2023; 15(21):5261. https://doi.org/10.3390/cancers15215261

Rodríguez-Lobato, Luis Gerardo, Natalia Tovar, Anna de Daniel, Carlos Fernández de Larrea, M. Teresa Cibeira, Raquel Jiménez-Segura, David F. Moreno, Aina Oliver-Caldés, Joan Bladé, and Laura Rosiñol. 2023. "Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution" Cancers 15, no. 21: 5261. https://doi.org/10.3390/cancers15215261

Rodríguez-Lobato, L. G., Tovar, N., de Daniel, A., Fernández de Larrea, C., Cibeira, M. T., Jiménez-Segura, R., Moreno, D. F., Oliver-Caldés, A., Bladé, J., & Rosiñol, L. (2023). Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution. Cancers, 15(21), 5261. https://doi.org/10.3390/cancers15215261